MedTrace Logo

Acute Kidney Injury in Critical COVID-19: Outcomes and Risks

NCT07089693 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 238

Last updated 2025-07-28

No results posted yet for this study

Summary

This retrospective observational study aims to determine the incidence of acute kidney injury (AKI) associated with COVID-19, risk factors, and effects on mortality for intensive care unit patients. Data from 238 COVID-19 patients monitored in the Anesthesiology and Reanimation Intensive Care Unit of Ankara University Ibni Sina Hospital between January 1, 2021 and January 1, 2022 were retrospectively reviewed. Patients were divided into two groups according to the level of renal damage (with and without AKI). Those with AKI were staged per the KDIGO criteria (Stage 1-2-3). Demographic data, comorbidities, Charlson comorbidity indexes, Acute Physiology and Chronic Health Evaluation scores, laboratory results, and mortality data were examined. The data obtained were compared between the groups.

The findings may help improve clinical awareness and guide management strategies in intensive care unit patients with COVID-19 at risk of AKI

Conditions

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • Gizem Kahraman, MD · Ankara University Department of Anesthesiology and Reanimation

  • Mustafa Kemal Bayar, Prof · Ankara University Department of Anesthesiology and Reanimation

  • Pınar Karabak Bilal, MD · Ankara University Department of Anesthesiology and Reanimation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-07-30
Completion
2022-08-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07089693 on ClinicalTrials.gov